Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.


Interferon beta-1a Product Approval Information - Licensing Action 5/17/96

Proper name: Interferon beta-1a
Tradename: Avonex
Manufacturer: Biogen, Inc, Cambridge, MA, License #1204 
Indication for Use: Treatment of relapsing forms of multiple sclerosis to slow the accumulation of physical disability and decrease the frequency of clinical exacerbations
Approval Date: 5/17/96
Type of submission: Product license application


Approval Letter (PDF)

Label (PDF)


Page Last Updated: 10/04/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English